SCHEMBL310198

SCHEMBL310198

O=C[C@H](O)[C@@](O)(F)[C@H](O)CO

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22692164 1.00 AKR1B1 (0.40) AKR1B1
SCHEMBL30500659 0.80 AKR1B1 (0.36) AKR1B1
SCHEMBL8857027 0.80 AKR1B1 (0.36) AKR1B1
SCHEMBL31757604 0.80 AKR1B1 (0.36) AKR1B1
SCHEMBL309710 0.80 AKR1B1 (0.36) AKR1B1
SCHEMBL458801 0.80 AKR1B1 (0.36) AKR1B1
SCHEMBL458624 0.80 AKR1B1 (0.36) AKR1B1
SCHEMBL31757603 0.80 AKR1B1 (0.36) AKR1B1
SCHEMBL184297 0.78 AKR1B1 (0.42) AKR1B1
SCHEMBL27688172 0.78 AKR1B1 (0.42) AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115803333-A Trinucleotide cap analogs, their preparation and use 生命技术公司 2023-03-14 CN disclosed
US-20230050863-A1 DICATIONIC FLUORESCENT DYES ROCHE MOLECULAR SYSTEMS, INC. 2023-02-16 US disclosed
US-11384376-B2 Reagents and methods for post-synthetic modification of nucleic acids ROCHE MOLECULAR SYSTEMS, INC. (US) 2022-07-12 US disclosed
US-20220143198-A1 COMPOSITIONS AND METHODS RELATED TO TETHERED KETHOXAL DERIVATIVES THE UNIVERSITY OF CHICAGO (US) 2022-05-12 US disclosed
US-20220002716-A1 TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF Life Technologies Corporation 2022-01-06 US disclosed
US-20210214773-A1 COMPOSITIONS AND METHODS RELATED TO KETHOXAL DERIVATIVES THE UNIVERSITY OF CHICAGO (US) 2021-07-15 US disclosed
WO-2021116037-A1 DICATIONIC FLUORESCENT DYES F. HOFFMANN-LA ROCHE AG (CH) 2021-06-17 WO disclosed
EP-3802863-A1 REAGENTS AND METHODS FOR POST-SYNTHETIC MODIFICATION OF NUCLEIC ACIDS F. Hoffmann-La Roche AG (CH) 2021-04-14 EP disclosed
EP-3790544-A1 COMPOSITIONS AND METHODS RELATED TO KETHOXAL DERIVATIVES The University of Chicago (US) 2021-03-17 EP disclosed
CN-112154214-A Reagents and methods for post-synthetic modification of nucleic acids 豪夫迈·罗氏有限公司 2020-12-29 CN disclosed
WO-2002044416-A2 SULFONATED DIARYLRHODAMINE DYES AS FLUORESCENT LABELS APPLERA CORPORATION (US) 2002-06-06 WO disclosed
WO-2002036832-A2 ATROPISOMERS OF ASYMMETRIC XANTHENE FLUORESCENT DYES AND METHODS OF DNA SEQUENCING AND FRAGMENT ANALYSIS APPLERA CORPORATION (US) 2002-05-10 WO disclosed
WO-2002030944-A2 FLUORESCENT NUCLEOBASE CONJUGATES HAVING ANIONIC LINKERS APPLERA CORPORATION (US) 2002-04-18 WO disclosed
EP-1196640-A2 ELECTRON-DEFICIENT NITROGEN HETEROCYCLE-SUBSTITUTED FLUORESCEIN DYES Applera Corporation (US) 2002-04-17 EP disclosed
US-6358679-B1 DETECTING TARGET NUCLEOTIDE SEQUENCES BY AMPLIFYING WITH FORWARD AND REVERSE PRIMER REAGANTS IN A SET OF ONE OR MORE VESSELS, AND AMPLIFYING A SINGLE STRANDED EXTERNAL CONTROL POLYNUCLEOTIDE WITH PRIMERS IN A SECOND SET OF VESSELS PE CORPORATION (NY) 2002-03-19 US disclosed
WO-2002016648-A2 METHODS FOR EXTERNAL CONTROLS FOR NUCLEIC ACID AMPLIFICATION PE CORPORATION (NY) (US) 2002-02-28 WO disclosed
US-6348596-B1 NUCLEIC ACID HYBRIDIZATION ASSAYS; DNA SEQUENCE DETERMINATION PE CORPORATION (NY) 2002-02-19 US disclosed
WO-2001083621-A2 SULFONATED [8,9]BENZOPHENOXAZINE DYES AND THE USE OF THEIR LABELLED CONJUGATES APPLERA CORPORATION (US) 2001-11-08 WO disclosed
WO-2001057264-A2 ELECTRON-DEFICIENT NITROGEN HETEROCYCLE-SUBSTITUTED FLUORESCEIN DYES APPLERA CORPORATION (US) 2001-08-09 WO disclosed
US-6221604-B1 CONJUGATED TO SUBSTRATES SUCH AS NUCLEOSIDES OR NUCLEOTIDES AND USED AS DETECTION LABELS IN MOLECULAR BIOLOGY EXPERIMENTS; ENERGY TRANSFER DYE PE CORPORATION 2001-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220002716-A1 TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF RNGTT, RNMT, CPSF7 AKR1B1 4453/4885
US-20220143198-A1 COMPOSITIONS AND METHODS RELATED TO TETHERED KETHOXAL DERIVATIVES KLK3, ANXA6, CKMT1A; CKMT1B AKR1B1 742/4885
US-20210214773-A1 COMPOSITIONS AND METHODS RELATED TO KETHOXAL DERIVATIVES RNMT, PHAX, RNGTT AKR1B1 1891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.